uMI Panorama
Shanghai United Imaging Healthcare Co., Ltd. • Radiology • 10/03/2023
Device Purpose
The uMI Panorama system is an advanced PET/CT imaging device designed to provide comprehensive metabolic, physiological, and anatomical information through the synergistic use of both modalities. It employs updated software, including the deep learning-enhanced uExcel Focus for improved motion correction and image accuracy, and the new uKinetics feature for quantitative parametric imaging, broadening its utility in oncology, cardiology, neurology, and lung cancer screening.
Summary
The uMI Panorama is a diagnostic imaging system that integrates Positron Emission Tomography (PET) and Computed Tomography (CT) functionalities. It is designed for qualified healthcare professionals to assist in the detection, localization, diagnosis, staging, restaging, treatment planning, and treatment response evaluation for a range of diseases, inflammation, infection, and disorders, with applications in oncology, cardiology, and neurology. The PET component provides quantitative information on the distribution of radiopharmaceuticals to assess metabolic and physiological functions, while the CT offers tomographic anatomical details and photon attenuation data. The system facilitates accurate registration and fusion of PET and CT images for precise anatomical referencing of PET findings and also supports standalone CT imaging, including low-dose CT for lung cancer screening. Technologically, the uMI Panorama features a PET system with either a 280mm or 350mm axial field of view (FOV) and a 160-slice CT system. This iteration introduces significant software enhancements: the uExcel Focus (OncoFocus) algorithm has been updated with deep learning technology to improve respiratory motion correction, leading to more accurate Standardized Uptake Values (SUV) and lesion volume measurements. A new function, uKinetics, has been added to generate both indirect and direct parametric images. Non-clinical and clinical evaluations demonstrated that uExcel Focus reduces motion artifacts and improves PET-CT alignment, while uKinetics provides quantitatively accurate parametric images, collectively enhancing the system's diagnostic capabilities.
AI Regulatory Concerns
Powered by
Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.
Keywords
Device Metadata
Relevant Clinical Questions
- Q1. How does the deep learning component within the updated uExcel Focus algorithm quantitatively compare to the previous version in terms of reducing respiratory motion artifacts across various breathing patterns and lesion sizes?; What specific kinetic models are implemented in the uKinetics feature, and how were they validated for generating accurate direct and indirect parametric images from PET data?; Could the uKinetics parametric imaging capabilities be extended to assess therapeutic response earlier or more precisely in specific oncological, cardiological, or neurological conditions beyond standard SUV metrics?; What are the trade-offs in terms of image acquisition time, patient radiation dose (from CT), and PET image signal-to-noise ratio when choosing between the 280mm and 350mm axial FOV options for different clinical scenarios?; Beyond the described benefits for oncology, cardiology, and neurology, what is the potential utility of uExcel Focus and uKinetics in assessing inflammation or infection, as mentioned in the general indications for use?
Risk Classification
ESL AnalysisFDA Class II via 510(k) pathway; IEC 62304 Class B (software safety classification); Authorized before §524B enforcement
Learn how Parasoft automates IEC 62304 compliance testing →Cybersecurity Evidence
Powered by SBOMator™Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.
Supply Chain BOM Evidence
Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.
Analysis:
• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.
• Evidence of ML-BOM detected in AI-generated device summary.
• This device was authorized before §524B took effect. Cybersecurity evidence requirements were less prescriptive at the time.
• Postmarket cybersecurity monitoring plan not clearly documented in AI-generated device summary.
• Not detected in AI-generated device summary: SBOM, SaaSBOM, HBOM, CBOM, VDR/VEX, OBOM. These may be present in the full FDA submission.
Preparing a similar submission?
ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.
Assess Your Readiness →Or contact ESL directly